grafts using porcine small intestinal submucosa in the repair of skin defects in 4 birds.
In vitro cytotoxicity and in vivo effects of a decellularized xenogeneic
collagen scaffold in nasal cartilage repair.
Decellularized allogeneic and xenogeneic
tissue as a bioscaffold for regenerative medicine: factors that influence the host response.
neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres.
Brehm et al., "Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic
graft-versus-host-like disease and the role of host major histocompatibility complex," Clinical & Experimental Immunology, vol.
[56.] Tetsuji Yamaoka, Effect of High Hydrostatic Pressure on Tissues and a Great Patency of Small-Diameter Xenogeneic
Acellular Blood Vessels with EPC Capturing Surface.
One of the three patients with soft tissue sarcoma-treated IL-2-transfected xenogeneic
cells (Vero-IL-2) showed durable reduction of two distant, noninjected metastases .
As expected, even though we used xenogeneic
MSCs in this model, we did not observe any immune response to the equine cells in the treated knees.
This might stimulate the antibody response to blood group-related xenogeneic
Wallace et al., "Xenogeneic
human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis," Oncotarget, vol.
Finally, we examined if the B cell-specific deletion of ILK might affect the in vivo IgM and IgG production against xenogeneic
Natural biological materials mainly include two types: autologous nonneural tissue, allogeneic, or decellularized xenogeneic
neural/nonneural tissues; natural polymers derived from extracellular matrix (ECM) (laminin, collagen, fibronectin, fibrin, and hyaluronic acid), polysaccharide (chitosan, sodium alginate, and agarose), and protein (silk fibroin, keratin). In China, chitosan-based conduit we developed has been approved for clinical trials with the national invention patent.
Other treatment options are marsupialization, and enucleation with allogeneic or xenogeneic
Despite the adequate characteristics and properties of the ECM as biomaterial, the use of an ECM of xenogeneic
origin involves an increased risk of immune rejection by the host, manifesting an inflammatory process.